| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.041 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |